Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAMD”

145 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 145 results

Testing effectiveness (Phase 2)Enrolling By InvitationNCT03999801
What this trial is testing

Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy

Who this might be right for
Neovascular Age-related Macular DegenerationWet Macular Degeneration
AbbVie 865
Large-scale testing (Phase 3)Active Not RecruitingNCT06223958
What this trial is testing

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Ocular Therapeutix, Inc. 344
Post-approval studies (Phase 4)Study completedNCT06591598
What this trial is testing

Learn About the Blood Levels of Aflibercept When High-dose Aflibercept is Injected in Both Eyes of Participants With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration

Who this might be right for
Diabetic Macular EdemaNeovascular Age-related Macular Degeneration
Bayer 51
Testing effectiveness (Phase 2)Looking for participantsNCT05672121
What this trial is testing

Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Age-Related Macular Degeneration
Chengdu Origen Biotechnology Co., Ltd. 42
Not applicableEnded earlyNCT05266495
What this trial is testing

Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3
Large-scale testing (Phase 3)Looking for participantsNCT05562947
What this trial is testing

The Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese Participants With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular DegenerationnAMD
Hoffmann-La Roche 68
Testing effectiveness (Phase 2)Looking for participantsNCT05986864
What this trial is testing

Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Skyline Therapeutics (US) Inc. 68
Post-approval studies (Phase 4)Looking for participantsNCT05093374
What this trial is testing

Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting

Who this might be right for
Exudative Macular Degeneration
Medical University of Vienna 290
Very early researchActive Not RecruitingNCT05099094
What this trial is testing

VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Shanghai BDgene Co., Ltd. 3
Testing effectiveness (Phase 2)Active Not RecruitingNCT04514653
What this trial is testing

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
AbbVie 146
Testing effectiveness (Phase 2)Temporarily pausedNCT05961007
What this trial is testing

Evaluation of IBI302 Injection in nAMD or DME

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular Edema
Innovent Biologics (Suzhou) Co. Ltd. 234
Large-scale testing (Phase 3)Ended earlyNCT03710564
What this trial is testing

Study of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF Injections

Who this might be right for
Age-Related Macular Degeneration
Novartis Pharmaceuticals 535
Early research (Phase 1)Study completedNCT05262244
What this trial is testing

Targeted Fluorescence Imaging in AMD

Who this might be right for
Age-Related Macular DegenerationNAMD
University Medical Center Groningen 12
Large-scale testing (Phase 3)Looking for participantsNCT07064759
What this trial is testing

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
4D Molecular Therapeutics 480
Testing effectiveness (Phase 2)Study completedNCT02507388
What this trial is testing

Safety and Pharmacokinetics of RTH258 in Subjects With Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Alcon Research 51
Testing effectiveness (Phase 2)Looking for participantsNCT05769153
What this trial is testing

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Alcon Research 140
Large-scale testing (Phase 3)Active Not RecruitingNCT06864988
What this trial is testing

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Macular Neovascularization Secondary to Age-Related Macular Degeneration
4D Molecular Therapeutics 480
Large-scale testing (Phase 3)Active Not RecruitingNCT04657289
What this trial is testing

The Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Hoffmann-La Roche 451
Testing effectiveness (Phase 2)Looking for participantsNCT06141460
What this trial is testing

Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Shanghai Refreshgene Technology Co., Ltd. 48
Early research (Phase 1)Active Not RecruitingNCT06198413
What this trial is testing

LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration
Innostellar Biotherapeutics Co.,Ltd 12
Load More Results